Induced pluripotent stem cell-derived natural killer cells therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Induced pluripotent stem cell-derived natural killer cells therapy, covering 2024-11-22 to 2024-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia [EARLY_Phase 1]